Forgot your password?
Haven't registered yet?
3/7/2014CMSC INforMS: Novartis currently recruiting for Phase 4 Gilenya study (PASSAGE)
2/4/2014CMSC INforMS: Genzyme’s Lemtrada Approved in Mexico for Treatment of Multiple Sclerosis
2/3/2014CMSC INforMS: Tecfidera Approved in the EU as a First-Line Oral Treatment for MS
1/28/2014CMSC INforMS: Teva Announces U.S. FDA Approval of Three-Times-a-Week COPAXONE 40mg/mL
1/24/2014CMSC Press Release: MS Annual Conference Presents the Latest on Diagnosis, Patient Care & Research
3/25/2013 » 3/25/2014MS Boot Camp: Calling All Recruits!
9/9/2013 » 9/9/2014Maximizing the Impact of Symptom Intervention in the Management of Patients with Multiple Sclerosis
2/12/2014 » 2/12/2015Individualized Learning Plan: Confronting Current Challenges in Multiple Sclerosis Treatment
5/28/2014 » 5/31/20142014 CMSC ACTRIMS Meeting
6/6/2014 » 6/7/201419th Annual RIMS Conference 2014